Company news

PreveCeutical Medical Inc news in 2025

PreveCeutical Medical Inc's news releases, calls and decks from 2025, newest first.

View company

PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology

December 4, 2025

PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement

November 26, 2025

CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)

November 24, 2025

PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.

November 20, 2025

PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

November 20, 2025

PreveCeutical Closes Second Tranche of Non-Brokered Private Placement

October 30, 2025

PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement

October 10, 2025

PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics

September 19, 2025

PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement

September 5, 2025

PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics

September 4, 2025

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation

August 28, 2025

BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

August 20, 2025

BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

August 19, 2025

PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

July 9, 2025

PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

June 30, 2025

PreveCeutical Announces Date for Annual General and Special Meeting

June 25, 2025

PreveCeutical Announces Non-Brokered Private Placement

June 11, 2025

PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

June 2, 2025

PreveCeutical Welcomes Stephen Glover as Corporate Advisor

May 26, 2025

PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

May 22, 2025

PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

May 14, 2025

PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement

April 28, 2025

PreveCeutical Announces Up-Sized Non-Brokered Private Placement

April 14, 2025

PreveCeutical Announces Update to Non-Brokered Private Placement

April 2, 2025

PreveCeutical Announces Update to Private Placement

March 10, 2025

Decks in 2025